| Nov 20 |
The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan
|
| Nov 20 |
Canopy Growth Launches Claybourne Infused Pre-Rolls in Canada
|
| Nov 11 |
Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024
|
| Nov 10 |
Avoid Canopy Growth
|
| Nov 9 |
Canopy Growth Corp (CGC) Q2 2025 Earnings Call Highlights: Navigating Revenue Challenges and ...
|
| Nov 8 |
Canopy Growth Corporation (CGC) Q2 2025 Earnings Call Transcript
|
| Nov 8 |
Canopy Growth sees positive earnings ahead thanks to cost savings
|
| Nov 8 |
Canopy Growth in charts: FQ2 Canada cannabis net revenue slips ~5% Y/Y, Storz & Bickel +32%
|
| Nov 8 |
Earnings Snapshot: Canopy Growth FQ2 revenue falls, adjusted EBITDA loss narrows
|
| Nov 8 |
Canopy Growth GAAP EPS of -C$1.52, revenue of C$73.96M
|
